Cyclica is the partner of choice for data-driven drug discovery.
Cyclica is the partner of choice for data-driven drug discovery. They advance molecules that embrace the complexity of the disease. They decentralize innovation with technology, build novel data-driven pipelines, and fuel cross-organizational collaborations at a molecular level.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 15, 2022 | Grant | $2.40M | 1 | Bill & Melinda Gates Foundation | — | Detail |
Jun 24, 2020 | Series B | $23M | 4 | Drive Capital | — | Detail |
Jul 1, 2019 | Series Unknown | — | 1 | — | — | Detail |
Jul 26, 2017 | Series A | $2.25M | 4 | GreenSky Capital | — | Detail |
Sep 22, 2016 | Series A | $2.40M | 2 | GreenSky Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Bill & Melinda Gates Foundation | Yes | Grant |
Drive Capital | Yes | Series B |
Chiesi Pharmaceuticals | — | Series B |
GreenSky Capital | — | Series B |
Naheed Kurji | — | Series B |
EPIC Capital | — | Series A |
Hanhai Studio | — | Series A |
Uni-Innovate Group | — | Series A |
China Canada Angel Alliance | — | Series A |
StartUp Health | — | Seed |